[Drug treatment of heart failure--what's new after the era of angiotensin converting enzyme inhibitors].
Gierlotka
M
M
III Katedra i Oddział Kliniczny Kardiologii Sl. AM Slaskiego Centrum Chorób Serca w Zabrzu.
Adamowicz-Czoch
E
E
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D009320:Atrial Natriuretic Factor / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D015507:Drugs, Investigational; D019332:Endothelin-1 / Q000037:antagonists & inhibitors*; D006333:Heart Failure / Q000188:drug therapy*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D015507:Drugs, Investigational; D019332:Endothelin-1; D006728:Hormones; D009320:Atrial Natriuretic Factor